Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Journal for ImmunoTherapy of Cancer

Fig. 3

From: Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy

Fig. 3

Multichannel immunofluorescence of renal mass and tumor thrombus. Representative images of residual tumor in the segmental renal vein that responded to therapy at low power (a) and high power (b) with clusters of co-localized CD8+ T cells and Batf3+ dendritic cells. The primary renal tumor staining pattern is shown at low power (c) and high power (d) featuring far fewer Batf3+ cells and CD8+ T cells

Back to article page